Switch’s $52 Million Financing

Wilson Sonsini Goodrich & Rosati advised Switch Therapeutics on the transaction and launch. Switch Therapeutics, a preclinical stage biotechnology company pioneering a new way to use…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here